Secondary Logo

Journal Logo

Most Popular Articles

Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFY

Potkin, Steven G.; Loze, Jean-Yves; Forray, Carlos; More

International Clinical Psychopharmacology. 32(3):147-154, May 2017.

Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders

Fineberg, Naomi A.; Hollander, Eric; Pallanti, Stefano; More

International Clinical Psychopharmacology. 35(4):173-193, July 2020.

Body dysmorphic disorder: a treatment synthesis and consensus on behalf of the International College of Obsessive-Compulsive Spectrum Disorders and the Obsessive Compulsive and Related Disorders Network of the European College of Neuropsychopharmacology

Castle, David; Beilharz, Francesca; Phillips, Katharine A.; More

International Clinical Psychopharmacology. 36(2):61-75, March 2021.

A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder

Fagiolini, Andrea; Albert, Umberto; Ferrando, Laura; More

International Clinical Psychopharmacology. 35(3):137-146, May 2020.

The effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and as adjunctive treatment in patients with major depressive disorder: an analysis of short-term and long-term studies

Weiss, Catherine; Weiller, Emmanuelle; Baker, Ross A.; More

International Clinical Psychopharmacology. 33(5):255-260, September 2018.

Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder

Fineberg, Naomi A.; Baldwin, David S.; Drummond, Lynne M.; More

International Clinical Psychopharmacology. 33(6):334-348, November 2018.

Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia: a pooled analysis of four phase II/III randomized, double-blind, placebo-controlled studies

Earley, Willie; Durgam, Suresh; Lu, Kaifeng; More

International Clinical Psychopharmacology. 32(6):319-328, November 2017.

The effectiveness and safety of cariprazine in schizophrenia patients with negative symptoms and insufficient effectiveness of previous antipsychotic therapy: an observational study

Rancans, Elmars; Dombi, Zsófia Borbála; Mátrai, Péter; More

International Clinical Psychopharmacology. 36(3):154-161, May 2021.

Effect of pimavanserin on anxious depression in patients with major depression and an inadequate response to previous therapy: secondary analysis of the clarity study

Papakostas, George I.; Fava, Maurizio; Freeman, Marlene P.; More

International Clinical Psychopharmacology. 35(6):313-321, November 2020.

Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 7-day randomized, double-blind, placebo-controlled exploratory study

Rancans, Elmars; Zambori, Janos; Dalsgaard, Mads; More

International Clinical Psychopharmacology. 35(6):305-312, November 2020.

Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized, double-blind, placebo-controlled trials

Thase, Michael E.; Edwards, John; Durgam, Suresh; More

International Clinical Psychopharmacology. 32(5):281-288, September 2017.

Methodological challenges in indirect treatment comparisons: spotlight on a recent comparison of long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia

Singh, Arun; Gopal, Srihari; Kim, Edward; More

International Clinical Psychopharmacology. 33(4):213-216, July 2018.

Off-label use of second-generation antipsychotics in borderline personality disorder: a comparative real-world study among oral and long-acting injectables in Spain

García-Carmona, Juan Antonio; Simal-Aguado, Jorge; Campos-Navarro, María Pilar; More

International Clinical Psychopharmacology. 36(4):201-207, July 2021.

Satisfaction of immediate or delayed switch to paliperidone palmitate in patients unsatisfied with current oral atypical antipsychotics

Kwon, Jun Soo; Kim, Sung Nyun; Han, Jaewook; More

International Clinical Psychopharmacology. 30(6):320-328, November 2015.

Changes in prolactin levels and sexual function in young psychotic patients after switching from long-acting injectable risperidone to paliperidone palmitate

Montalvo, Itziar; Ortega, Laura; López, Xavi; More

International Clinical Psychopharmacology. 28(1):46-49, January 2013.

A randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release and a long-term extension study for patients with major depressive disorder in Japan

Higuchi, Teruhiko; Kamijima, Kunitoshi; Nakagome, Kazuyuki; More

International Clinical Psychopharmacology. 31(1):8-19, January 2016.

Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: systematic review and indirect treatment comparison

Pae, Chi-Un; Wang, Sheng-Min; Han, Changsu; More

International Clinical Psychopharmacology. 32(5):235-248, September 2017.

Effects of vilazodone on sexual functioning in healthy adults: results from a randomized, double-blind, placebo-controlled, and active-controlled study

Clayton, Anita H.; Durgam, Suresh; Li, Dayong; More

International Clinical Psychopharmacology. 32(1):27-35, January 2017.

Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression

Thase, Michael E.; Nierenberg, Andrew A.; Vrijland, Peter; More

International Clinical Psychopharmacology. 25(4):189-198, July 2010.

Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany

Post, Robert M.; Leverich, Gabriele S.; Altshuler, Lori L.; More

International Clinical Psychopharmacology. 26(2):96-106, March 2011.

Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial

Farajollahi-Moghadam, Mostafa; Sanjari-Moghaddam, Hossein; Ghazizadeh Hasemi, Maryam; More

International Clinical Psychopharmacology. 36(3):140-146, May 2021.